This limited efficacy contrasts with the more pronounced tumor-suppressive effects observed following genetic depletion of KSR1, where siRNA- or knockout-mediated suppression of KSR1 markedly impaired cell proliferation, induced apoptosis, and reduced tumor growth in both in vitro and in vivo models [80,83,97]. This evidence concerns the gene KSR1 and neoplasm.